TickerFacts.

OS Therapies Inc (OSTX): Free Cash Flow

Operating cash flow minus capital expenditures for the same annual period and currency, computed by TickerFacts from the filed figures. A simple proxy, not a reported figure; a year without both inputs is left out.

-$14.70M
Year ended 2025-12-31
Period endedFree Cash FlowChange YoYSource filing
2025-12-31-$14.70Mn/a2026-03-31, From 2025-01-01

Free Cash Flow at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedFree Cash FlowChange YoY
OS Therapies Inc (OSTX)2025-12-31-$14.70Mn/a
Serina Therapeutics, Inc. (SER)2025-12-31-$18.01Mn/m
CV Sciences, Inc. (CVSI)2025-12-31-$516.0Kn/m
Cannapharmarx, Inc. (CPMD)2025-12-31-$794.6Kn/m
GeoVax Labs, Inc. (GOVX)2025-12-31-$21.50Mn/m
Ensysce Biosciences, Inc. (ENSC)2025-12-31-$7.93Mn/a
Oncolytics Biotech Inc (ONCY)2025-12-31-$20.12Mn/m
Processa Pharmaceuticals, Inc. (PCSA)2024-12-31-$11.25Mn/m
Ernexa Therapeutics Inc. (ERNA)2025-12-31-$7.05Mn/m

Compare OSTX, SER, CVSI, CPMD side by side · Screen every company in Pharmaceutical Preparations ↗